Internal Server Error

About Nextrans

Nextrans is a venture capital firm founded in 2012. It is primarily based out of Seoul, South Korea. As of May 2024, Nextrans has invested in 54 companies. It primarily invests in Seed round in Vietnam based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to Consumer and Life Sciences. Most recently it participated in the $***** Series B round of MedInTech Overall, Nextrans portfolio has seen 3 IPOs and 3 acquisitions including key companies like Base, OrphAI Therapeutics and Hyperfine. A lot of funds co-invest with Nextrans, with names like BonAngels Venture Partners sharing a substantial percentage of its portfolio. Nextrans has team of 5 people including 5 partners.
Key Metrics
Portfolio Count
Portfolio Locations
Rounds of Entry
Seed, Conventional Debt & 2 more
Portfolio Acquisitions
Portfolio Soonicorns

Nextrans' List of Top Investments

Nextrans has a portfolio of 54 companies. Their most notable investments are in Base and Ecomobi.Their portfolio spans across South Korea, United States, Vietnam and 1 more locations. They have invested in Enterprise Applications, Consumer, Life Sciences and 22 other sectors, across stages such as Seed, Conventional Debt  and 2 more. Here is the list of top investments by Nextrans:

1. Bioz

Developer of AI search engine for scientific experimentation. This platform provides researchers with scientific experimentation data, insights, and recommendations for products, equipment, and assays that help in drug discovery and finding cures for diseases.

Key facts about Bioz

  • Founded Year: 2013
  • Location: Los Altos (United States)
  • Stage: Series A
  • Total Funding till date: $17.5M
  • Employee Count: 57 as on May 31, 2026
  • Investors: StartX, SV Latam Capital and 13 Others
  • Latest Funding Round: Grant (prize money), Apr 15, 2020, $*****
  • Highlight: Editors' Pick
Online platform providing English language learning solutions. The platform offers its solutions for both students as well as tutors. The platform enables students to learn English from tutors whereas tutors to register for teaching English.

Key facts about Ringle

Igaworks provides demand side advertising platform and audience targeting platform capable of implementing the advertisement required for each application life cycle. Started as an In-game advertisement company later shifted its focus on mobile ad tracking and app analytics platform. In addition, the TF2 platform also allows sending targeted ads to Facebook users based on the analytics performed on Facebook data.

Key facts about IGAWorks

  • Founded Year: 2006
  • Location: Seoul (South Korea)
  • Stage: Series C
  • Total Funding till date: $10.9M
  • Employee Count: 124 as on May 31, 2026
  • Investors: SBVA, Groom Investment and 18 Others
  • Latest Funding Round: Series C, Nov 10, 2015, $*****
  • Highlight: Editors' Pick
Provider of precision medicines for veterinary cancer. The company offers different drug combinations suited for a certain cancer pet patient. The company biopsies the live cancer cells for drug responses before treatment. Based on these responses, the company uses its data-driven technology to help veterinary oncologists to fix a personalized medicinal regime for an individual.

Key facts about ImpriMed

  • Founded Year: 2017
  • Location: Palo Alto (United States)
  • Stage: Series A
  • Total Funding till date: $34.9M
  • Employee Count: 44 as on May 31, 2026
  • Investors: SK Telecom, StartX and 26 Others
  • Latest Funding Round: Series A, Nov 06, 2023, $*****
  • Highlight: Editors' Pick
Developer of digital information storage system. The company is developing a DNA-based platform for massive digital data storage and computation and it has potential to generate 160 zettabytes of data.

Key facts about Catalog Technologies

Nextrans' Investments by Stage

Nextrans has made 4 investments in Seed stage with an average round size of $1.18M, 1 investment in Conventional Debt stage with an average round size of $4.5M, 1 investment in Series A stage and 1 investment in Series B stage with an average round size of $14.6M.
Here are Nextrans' investments by stage:
Stage of entry
No. of Investments
Seed
4
Conventional Debt
1
Series A
1
Series B
1
Breakdown of Nextrans' investments by stage of entrySeed (4)Conventional Debt (1)
Note: We have considered here, only first round of investments

Nextrans' Investments by Sector

Nextrans has a diverse portfolio, with companies operating in the Enterprise Applications, Consumer, HealthTech, Retail and Business Services. Notably, it has invested in 48 Tech companies, 30 Enterprise (B2B) companies, 23 Consumer (B2C) companies and at least 22 companies focusing on Software.
Here are Nextrans' investments by sector:
Sector
No. of Investments
Enterprise Applications
3
Consumer
2
HealthTech
2
Retail
2
Business Services
1
Others
3
Breakdown of Nextrans' investments by sectorsEnterprise Applic... (3)Consumer (2)
Note: We have considered here, only first round of investments

Nextrans' Investments by Geography

Nextrans has made most investments in Vietnam (5), followed by South Korea where it has made 2 investments.
Here are Nextrans' investments by geography:
Country
No. of Investments
Vietnam
5
South Korea
2
Breakdown of Nextrans' investments by countriesVietnam (5)South Korea (2)
Note: We have considered here, only first round of investments

Nextrans' recent investments

Nextrans has not made any investment in 2026 so far.
Here are the most recent investments by Nextrans:
Date
Company
Location
Round Details
Round Amount
Co-Investors
May 13, 2024
South Korea
Series B
8272
Mar 26, 2024
South Korea
Seed
9190
Apr 01, 2020
Vietnam
Seed
3166
Jul 01, 2019
Vietnam
Series A
4860
-
May 22, 2019
Vietnam
Conventional Debt
7287
  [+5]

IPOs and Publicly Listed companies in Nextrans' Portfolio

3 of Nextrans' portfolio companies have become public. ROKIT Healthcare got listed on the Korea Exchange (KRX), in May 2025 at marketcap of $76.4M and Hyperfine got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ).
Here are Nextrans' portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
May 12, 2025
-
-
5592
Jan 27, 2021
-
-
4325
-
Apr 01, 2020
Seed
9978

Acquired companies in Nextrans' Portfolio

3 companies from Nextrans' portfolio have been acquired. The most recent acquisition was OrphAI Therapeutics in May 2026 by Quince Therapeutics for $*****.
Here are Nextrans' portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
May 18, 2026
-
-
8364
Apr 13, 2023
-
-
1720
May 04, 2021
Jul 01, 2019
Series A
3734

Team profile of Nextrans

Nextrans has a team of 5 members including 5 Partners located in South Korea. Nextrans' team does not sit on the board of any company as of now.
Here is a list of all team members in Nextrans:
Name
Designation
Location
Board Memberships
Contact Details
Partner
South Korea
-
-
Partner
South Korea
-
-
Partner
-
-
-
Partner
South Korea
-
-
Partner
Seoul
-
-

Co-investors of Nextrans

Over the past 8 years, 34 investors have co-invested in Nextrans's portfolio companies. This includes funds and angels.

  • Invested before NextransESP Capital, Alpha JWC Ventures and 11 others have invested in rounds before Nextrans. There are 2 companies where ESP Capital has invested before Nextrans and 1 company where Alpha JWC Ventures has invested before Nextrans.
  • Top Co-investors of Nextrans16 investors entered a company along with Nextrans. These include investors like BonAngels Venture Partners (3 companies).
  • Invested after NextransA total of 5 investors have invested in Nextrans's portfolio after their investments. Top Investors include CyberAgent (1 company), VinaCapital (1 company) and NAVER (1 company).

Recent News related to Nextrans

View all news related to Nextrans

FAQs about Nextrans

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford